Qingxin (Ken) Liu
VP of Regional Operations, Hangzhou
I am responsible for the daily operations of our Hangzhou site where we develop and deliver new RabMAb antibodies and produce recombinant antibodies for our global customers. Our ‘New Product Development’ team collaborates with global customers to deeply understand their requirements and develop de novo products and solutions.
Something I am extremely proud of is our team’s contribution and resilience during COVID-19. Our site managers have created a safe environment to ensure every employee can safely work from the office or from their home. As a result of everyone’s dedication and flexibility, we preserved employee safety at all times without impacting our development and production timelines.
As part of Abcam, I am delighted to see how our work is supporting Chinese researchers by providing high-quality reagents, helping them to progress their science.